NASDAQ:IBB   iShares Biotechnology ETF
probably tests trendline resistance again

Related Ideas

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.